Apixaban, rivaroxaban, and dabigatran are all DOAC blood thinners, but their side effect profiles differ significantly. Apixaban has the lowest bleeding risk, especially in the gut. Rivaroxaban increases major bleeding risk. Dabigatran may raise heart attack risk. Choose based on your health history.